REG - AIM - Schedule One - DSW Capital PLC

LMS CapitalAnnouncement

02/11/2021 09:00

RNS Number : 9538Q
  
AIM
  
02 November 2021
  
 




ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")










COMPANY NAME:




DSW Capital plc ("DSW" or the "Company") 
 




COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :




7400 Daresbury Park
Daresbury
Warrington
WA4 4BS
 




COUNTRY OF INCORPORATION:




England & Wales
 




COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:




https://www.dswcapital.com/  
 




COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY).  IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:




 
DSW is a challenger mid-market professional services business headquartered in the Northwest of England. DSW operates a licencing model and licences the DSW and associated brand names in return for a royalty based on a percentage of fee income.
 
The DSW network currently employs 81 fee earners across England and Scotland.  DSW recruits highly skilled professionals (typically "Big 4"), in focused niches of expertise to run their own business and provide services to mid-market corporates, owner managers, private equity firms and high net worth individuals
 
Trademark agreements are in place with all network businesses with some arrangements also including a profit share where DSW takes an equity stake in the licensee business.
 




DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):




 
TBC Ordinary Shares of TBC pence each ("Ordinary Shares").
 
No restrictions on the transferability of the Ordinary Shares.
 




CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:




 
Capital to be raised on Admission: £5 million
Secondary offering on Admission: None
Market capitalisation on Admission: £TBC million 
 




PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:




TBC per cent.
 




DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:




None
 




FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):




 
Heather Louise Lauder, Independent Non-Executive Chair
James Alexander Thomas Dow, Chief Executive Officer
Nicole Jane Burstow, Chief Financial Officer
Jillian Margaret Jones, Independent Non-Executive Director
Jonathan Hugh Schofield, Non-Executive Director
 




FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):




 
The Company's current significant shareholders are:
 



Shareholder


Percentage of Ordinary Shares as at date of this document


Anticipated percentage of Ordinary Share post-Admission




James Dow


31.58%


TBC




Jon Schofield


21.05%


TBC




Mark Watts


21.05%


TBC




Philip Price


10.53%


TBC




Andrew Dodd


10.53%


TBC




Craig Richardson


5.26%


TBC



 
 




NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:




None
 




(i)         ANTICIPATED ACCOUNTING REFERENCE DATE 
(ii)        DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)
(iii)       DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:




(i)         31 March
(ii)        30 September 2021
(iii)       30 September 2022 (in respect of annual report to 31 March 2022)
31 December 2022 (in respect of the half yearly report to 30 September 2022)
30 September 2023 (in respect of the annual report to 31 March 2023)
 




EXPECTED ADMISSION DATE:




Early December 2021
 




NAME AND ADDRESS OF NOMINATED ADVISER:




Shore Capital and Corporate Limited
Cassini House
57 St James's Street
London
SW1A 1LD
 




NAME AND ADDRESS OF BROKER:




Shore Capital Stockbrokers Limited
Cassini House
57 St James's Street
London
SW1A 1LD
 




OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:




 
Copies of the admission document will be available free of charge at the registered office of the Company at 7400 Daresbury Park, Daresbury, Warrington, WA4 4BS, during normal business hours on any day (except Saturdays, Sundays and public holidays) for one month from the date of Admission.
 
The admission document will also be available at the Company's website www.dswcapital.com from the date of Admission.
 
The admission document will contain full details about the applicant and the admission of its securities.
 




THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY




The Company has adopted the UK Corporate Governance Code, published by the UK Quoted Companies Alliance 
 




DATE OF NOTIFICATION:




2 November 2021
 




NEW/ UPDATE:




New
 



 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
PAAFSMFLFEFSELF